Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting beta-catenin signalling
Xiuli Bi1, Yuqing Zhao, Wenfeng Fang
1Department of Pathology, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Abstract:
1. The Wnt/beta-catenin pathway plays a critical role in carcinogenesis and so agents that target Wnt/beta-catenin may have potential in cancer prevention and therapy. The aim of the present study was to evaluate the anticancer activity of the novel natural product dammarane-type triterpene sapogenin (20(S)-25-OCH3-PPD; PPD25) isolated from the leaves of Panax notoginseng. 2. The anticancer activity of PPD25 was evaluated in three colon cancer cell lines and in one lung cancer cell line. The effects of PPD25 to inhibit proliferation and to induce apoptosis were evaluated. In addition, the potential mechanisms underlying the effects of PPD25 were investigated. 3. It was found that the addition of 5 or 25 micromol/L PPD25 to the culture medium significantly inhibited cell proliferation and induced apoptosis in all four cancer cell lines. Mechanistic studies revealed that PPD25 significantly reduced the expression of beta-catenin, a key mediator in the Wnt pathway, as well as transcriptional targets of beta-catenin, namely c-myc, cyclin D1, cdk4 and T cell factor (TCF)-4. In addition, beta-catenin/TCF transcriptional activity was significantly suppressed by PPD25. 4. The data demonstrate that the PPD25 exerts its anticancer effect by targetting beta-catenin signalling, suggesting that PPD25 may have potential as a chemotherapeutic and/or chemopreventive agent for colon and lung cancer.
Insights
A novel compound, PPD25, derived from Panax notoginseng, effectively inhibits cancer cell growth and promotes apoptosis. It targets the Wnt/beta-catenin pathway, showing potential for cancer prevention and therapy.
Area of Science:
- Natural Products Chemistry
- Molecular Biology
- Cancer Research
Background:
- The Wnt/beta-catenin pathway is crucial in cancer development.
- Targeting this pathway offers potential for cancer prevention and treatment.
- Natural products are a source of novel anticancer agents.
Purpose of the Study:
- To investigate the anticancer activity of dammarane-type triterpene sapogenin (20(S)-25-OCH3-PPD; PPD25).
- To evaluate PPD25's effects on colon and lung cancer cell lines.
- To elucidate the molecular mechanisms underlying PPD25's anticancer effects.
Main Methods:
- Anticancer activity was assessed in four cancer cell lines (3 colon, 1 lung).
- Inhibition of cell proliferation and induction of apoptosis were measured.
- Western blotting and reporter assays were used to study pathway modulation.
Main Results:
- PPD25 significantly inhibited proliferation and induced apoptosis in all tested cancer cell lines.
- PPD25 reduced the expression of beta-catenin and its downstream targets (c-myc, cyclin D1, cdk4, TCF-4).
- PPD25 suppressed beta-catenin/TCF transcriptional activity.
Conclusions:
- PPD25 exhibits anticancer properties by targeting the Wnt/beta-catenin signaling pathway.
- PPD25 demonstrates potential as a chemotherapeutic or chemopreventive agent for colon and lung cancers.
- Further research into PPD25 is warranted for cancer treatment strategies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Abnormal Proliferation

